全球银屑病药物市场规模研究与预测：按药物类别、分子类型、给药途径和地区分析，2022-2029 年

牛皮癣是一种皮肤病，皮肤细胞的更新速度比正常情况快。

牛皮癣与免疫系统有关，最常见于膝盖、肘部、躯干和头皮。银屑病发病率上升、对各种可用治疗方案的认识不断提高以及主要市场参与者的战略举措是推动市场增长的关键因素。

根据国家银屑病基金会的数据，截至 2020 年，美国约有 800 万人患有银屑病。全球约有1.25亿人患有银屑病，占世界人口的2-3%以上。此外，世界卫生组织 (WHO) 估计全世界约有 1 亿人患有牛皮癣。此外，新兴国家医疗基础设施的发展和製药行业研发活动的增加有望在预测期内为市场提供良好的增长前景。然而，与牛皮癣治疗相关的高昂治疗费用和与药物治疗相关的健康风险将阻碍整个 2022-2029 年预测期内的市场增长。

全球银屑病治疗市场研究考虑的主要区域包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于主要市场参与者的存在以及该地区银屑病患病率的增加，北美已成为市场份额的领先地区。另一方面，由于药品价格上涨和皮肤病增加等因素，预计亚太地区在预测期内将出现显着增长。

本报告中的主要市场进入者包括：

• Astellas Pharma Inc.
• AstraZeneca plc
• Boehringer Ingelheim GmbH
• F. Hofffmann-La Roche
• GlaxoSmithKline plc
• Merck and Co., Inc.
• Valeant Pharmaceuticals International, Inc.
• Biocon Limited
• Eli Lilly and Company
• G and W Laboratories Inc.

市场的最新发展。

• 2021 年 10 月，印度的 Sun Pharmaceuticals Ltd. 在加拿大推出了一种名为 ILUMYA 的药物，用于治疗成人中度至重度斑块状银屑病。
• 2021 年 12 月，美国食品和药物管理局批准扩大使用安进公司的药物 Otezla 治疗成人轻度至中度斑块状银屑病。这一批准使 Otezla 成为第一个也是唯一一个可用于成人寻常型银屑病的口服治疗选择。

全球银屑病药物市场研究范围。

历史数据：2019-2020-2021

估计基准年：2021

预测期间：2022-2029

报告涵盖的收入预测、公司排名、竞争格局、增长因素、趋势

靶点治疗分类、分子类型、给药途径、区域

区域范围北美、欧洲、亚太地区、拉丁美洲、世界其他地区

覆盖率报告的自定义是免费的（最多 8 小时的分析师时间）。添加或更改国家、地区或细分范围*。

这项研究的目的是定义近年来各个细分市场和国家的市场规模，并预测他们在未来几年的价值。该报告旨在捕捉被调查国家工业的定性和定量方面。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。此外，它还包含供利益相关者投资的微观市场潜在机会，以及对主要参与者的竞争格局和产品供应的深入分析。市场的详细细分和子细分如下所述。

按药物类别

肿瘤坏死因子抑製剂

PDE4抑製剂

白细胞介素阻滞剂

杂项

按分子类型

生物製品

低分子化合物

按给药途径

口语

亲子

局部给药

按地区

北美

美国

加拿大

欧洲

英国

德国

法国

西班牙

意大利

其他欧洲

亚太地区

中国

印度

日本

澳大利亚

韩国

其他亚太地区

拉丁美洲

巴西

墨西哥

世界其他地区

内容

第 1 章执行摘要

• 市场概况
• 2019-2029 年各细分市场的全球市场估计和预测
  • 银屑病药物市场（按地区）：2019-2029
  • 按药物类别划分的银屑病药物市场：2019-2029
  • 银屑病药物市场（按分子类型）：2019-2029
  • 按给药途径划分的银屑病药物市场：2019-2029
• 主要趋势
• 调查方法
• 调查先决条件

第 2 章银屑病药物的全球市场定义和范围

• 调查的目的
• 市场定义和范围
  • 调查范围
  • 工业发展
• 调查年份
• 货币兑换率

第三章全球银屑病药物市场动态

• 银屑病药物市场影响分析（2019-2029）
  • 市场驱动力
    • 银屑病的发病率增加。
    • 提高了对各种可用治疗方案的认识。
    • 主要市场参与者的战略举措。
  • 市场挑战
    • 银屑病治疗相关的高昂治疗费用
    • 与药物治疗相关的健康风险
  • 市场机会
    • 新兴国家/地区医疗保健基础设施的扩展
    • 在製药领域开展研发活动

第四章银屑病药物全球市场行业分析

• 波特 5 力模型
  • 供应商的议价能力
  • 买家的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争公司之间的敌对关係
• 波特 5 力模型的未来方法 (2019-2029)
• 害虫分析
  • 政治
  • 经济的
  • 社交
  • 技术
• 投资招聘模式
• 分析师的结论和建议
• 顶级投资机会
• 关键成功策略

第 5 章风险评估 COVID-19 影响

• 评估 COVID-19 对行业的总体影响
• COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球银屑病药物市场：按药物类别分类

• 市场概况
• 全球银屑病药物市场：按药物类别、性能-潜力分析
• 2019-2029 年全球银屑病药物市场、按药物类别估计和预测
• 银屑病治疗药物市场细分分析
  • 肿瘤坏死因子抑製剂
  • PDE4抑製剂
  • 白细胞介素阻滞剂
  • 其他

第 7 章全球银屑病药物市场：按分子类型

• 市场概况
• 银屑病药物的全球市场：按分子类型进行性能潜力分析
• 全球银屑病药物市场、分子类型估计和预测 (2019-2029)
• 银屑病治疗药物市场细分分析
  • 生物製品
  • 低分子化合物

第 8 章全球银屑病药物市场：按给药途径

• 市场概况
• 全球银屑病药物市场：按给药途径进行的性能-潜力分析
• 全球银屑病药物市场、按给药途径估计和预测（2019-2029 年）
• 银屑病治疗药物市场细分分析
  • 口服剂
  • 父母代理人
  • 局部管理

第 9 章银屑病药物的全球市场：区域分析

• 银屑病药物市场，按地区划分的市场概况
• 北美
  • 美国
    • 2019-2029 年按药物类别的估计和预测
    • 按分子类型估计和预测，2019-2029
    • 按给药途径估算和预测，2019-2029 年
  • 加拿大
• 欧洲银屑病药物市场概况
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 意大利
  • 其他欧洲地区
• 亚太地区银屑病药物市场概况
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 韩国
  • 其他亚太地区
• 拉丁美洲银屑病药物市场概况
  • 巴西
  • 墨西哥
• 世界其他地方

第 10 章衝突信息

• 顶级市场策略
• 公司简介
  • Astellas Pharma Inc.
    • 主要信息
    • 概览
    • 财务（如果有数据）
    • 产品概览
    • 近期发展状况
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • F. Hofffmann-La Roche
  • GlaxoSmithKline plc
  • Merck and Co., Inc.
  • Valeant Pharmaceuticals International, Inc.
  • Biocon Limited
  • Eli Lilly and Company
  • G and W Laboratories Inc.

第 11 章研究过程

• 研究过程
  • 数据挖掘
  • 分析
  • 市场评估
  • 验证
  • 出版
• 调查属性
• 调查先决条件

Global Psoriasis Therapeutics Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Psoriasis is a type of skin disorders which causes skins cells to replace more quickly than normal. Psoriasis is associated with immune system and most commonly occurs on knees, elbows, trunk, and scalp. The increasing incidences of Psoriasis disease and rising awareness towards different treatment options available as well as strategic initiatives from leading market players are key factors accelerating the market growth.

According to National Psoriasis Foundation, USA - as of 2020, around 8 million individuals in the United States are affected by Psoriasis. In addition, around 125 million people worldwide suffers from Psoriasis, witnessing for over 2 to 3 percent of the global population. Moreover, as per World Health Organization (WHO) estimates - approximately 100 million individuals worldwide are affected by Psoriasis. Also, rising healthcare infrastructure in emerging economies and increasing R&D activities in pharmaceuticals sector would create lucrative growth prospectus for the market over the forecast period. However, high treatment cost associated with Psoriasis treatment and health risks associated with medications impede the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Psoriasis Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the; leading region in terms of market share owing to presence of leading market players as well as increasing prevalence of Psoriasis in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising pharmaceuticals sector as well as increasing incidences of skin disorders in the region.

Major market players included in this report are:

Astellas Pharma Inc.

AstraZeneca plc

Boehringer Ingelheim GmbH

F. Hofffmann-La Roche

GlaxoSmithKline plc

Merck and Co., Inc.

Valeant Pharmaceuticals International, Inc.

Biocon Limited

Eli Lilly and Company

G and W Laboratories Inc.

Recent Developments in the Market:

• In October 2021, India based Sun Pharmaceuticals Ltd. unveiled its medicine named ILUMYA for the treatment of adults with moderate-to-severe plaque psoriasis in Canada.
• In December 2021, The Food and Drug Administration of USA has approved the expanded use of Amgen Inc's drug Otezla for the treatment of adults with mild to moderate plaque psoriasis. With this approval Otezla would be the first and only oral treatment option available for plaque psoriasis in adults.

Global Psoriasis Therapeutics Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered Drug Class, Molecule Type, Route of Administration, Region

Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class

TNF Inhibitors

PDE4 Inhibitors

Interleukin Blockers

Others

By Molecule Type

Biologics

Small Molecules

By Route of Administration

Oral

Parenteral

Topical

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Psoriasis Therapeutics Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Psoriasis Therapeutics Market, by Drug Class, 2019-2029 (USD Billion)
  • 1.2.3. Psoriasis Therapeutics Market, by Molecule Type, 2019-2029 (USD Billion)
  • 1.2.4. Psoriasis Therapeutics Market, by Route of Administration, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Psoriasis Therapeutics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Psoriasis Therapeutics Market Dynamics

• 3.1. Psoriasis Therapeutics Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidences of Psoriasis disease.
    • 3.1.1.2. Rising awareness towards different treatment options available.
    • 3.1.1.3. Strategic initiatives from leading market players.
  • 3.1.2. Market Challenges
    • 3.1.2.1. High treatment cost associated with Psoriasis treatment.
    • 3.1.2.2. Health risks associated with medications.
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising healthcare infrastructure in emerging economies.
    • 3.1.3.2. Increasing R&D activities in pharmaceuticals sector.

Chapter 4. Global Psoriasis Therapeutics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Psoriasis Therapeutics Market, by Drug Class

• 6.1. Market Snapshot
• 6.2. Global Psoriasis Therapeutics Market by Drug Class, Performance - Potential Analysis
• 6.3. Global Psoriasis Therapeutics Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
• 6.4. Psoriasis Therapeutics Market, Sub Segment Analysis
  • 6.4.1. TNF Inhibitors
  • 6.4.2. PDE4 Inhibitors
  • 6.4.3. Interleukin Blockers
  • 6.4.4. Others

Chapter 7. Global Psoriasis Therapeutics Market, by Molecule Type

• 7.1. Market Snapshot
• 7.2. Global Psoriasis Therapeutics Market by Molecule Type, Performance - Potential Analysis
• 7.3. Global Psoriasis Therapeutics Market Estimates & Forecasts by Molecule Type 2019-2029 (USD Billion)
• 7.4. Psoriasis Therapeutics Market, Sub Segment Analysis
  • 7.4.1. Biologics
  • 7.4.2. Small Molecules

Chapter 8. Global Psoriasis Therapeutics Market, by Route of Administration

• 8.1. Market Snapshot
• 8.2. Global Psoriasis Therapeutics Market by Route of Administration, Performance - Potential Analysis
• 8.3. Global Psoriasis Therapeutics Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
• 8.4. Psoriasis Therapeutics Market, Sub Segment Analysis
  • 8.4.1. Oral
  • 8.4.2. Parenteral
  • 8.4.3. Topical

Chapter 9. Global Psoriasis Therapeutics Market, Regional Analysis

• 9.1. Psoriasis Therapeutics Market, Regional Market Snapshot
• 9.2. North America Psoriasis Therapeutics Market
  • 9.2.1. U.S. Psoriasis Therapeutics Market
    • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Molecule Type breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. Route of Administration breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Psoriasis Therapeutics Market
• 9.3. Europe Psoriasis Therapeutics Market Snapshot
  • 9.3.1. U.K. Psoriasis Therapeutics Market
  • 9.3.2. Germany Psoriasis Therapeutics Market
  • 9.3.3. France Psoriasis Therapeutics Market
  • 9.3.4. Spain Psoriasis Therapeutics Market
  • 9.3.5. Italy Psoriasis Therapeutics Market
  • 9.3.6. Rest of Europe Psoriasis Therapeutics Market
• 9.4. Asia-Pacific Psoriasis Therapeutics Market Snapshot
  • 9.4.1. China Psoriasis Therapeutics Market
  • 9.4.2. India Psoriasis Therapeutics Market
  • 9.4.3. Japan Psoriasis Therapeutics Market
  • 9.4.4. Australia Psoriasis Therapeutics Market
  • 9.4.5. South Korea Psoriasis Therapeutics Market
  • 9.4.6. Rest of Asia Pacific Psoriasis Therapeutics Market
• 9.5. Latin America Psoriasis Therapeutics Market Snapshot
  • 9.5.1. Brazil Psoriasis Therapeutics Market
  • 9.5.2. Mexico Psoriasis Therapeutics Market
• 9.6. Rest of The World Psoriasis Therapeutics Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Astellas Pharma Inc.
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. AstraZeneca plc
  • 10.2.3. Boehringer Ingelheim GmbH
  • 10.2.4. F. Hofffmann-La Roche
  • 10.2.5. GlaxoSmithKline plc
  • 10.2.6. Merck and Co., Inc.
  • 10.2.7. Valeant Pharmaceuticals International, Inc.
  • 10.2.8. Biocon Limited
  • 10.2.9. Eli Lilly and Company
  • 10.2.10. G and W Laboratories Inc.

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Psoriasis Therapeutics Market, report scope
• TABLE 2. Global Psoriasis Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Psoriasis Therapeutics Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
• TABLE 4. Global Psoriasis Therapeutics Market estimates & forecasts by Molecule Type 2019-2029 (USD Billion)
• TABLE 5. Global Psoriasis Therapeutics Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
• TABLE 6. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 17. U.S. Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. U.S. Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 20. Canada Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. Canada Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 23. UK Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. UK Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 26. Germany Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. Germany Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 29. France Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. France Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 32. Italy Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Italy Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 35. Spain Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. Spain Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 38. RoE Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. RoE Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 41. China Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. China Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 44. India Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. India Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 47. Japan Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. Japan Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 50. South Korea Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. South Korea Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 53. Australia Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. Australia Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. RoAPAC Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 59. Brazil Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Brazil Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 62. Mexico Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. Mexico Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 65. RoLA Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. RoLA Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 68. Row Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. Row Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 70. List of secondary sources, used in the study of global Psoriasis Therapeutics Market
• TABLE 71. List of primary sources, used in the study of global Psoriasis Therapeutics Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Psoriasis Therapeutics Market, research methodology
• FIG 2. Global Psoriasis Therapeutics Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Psoriasis Therapeutics Market, key trends 2021
• FIG 5. Global Psoriasis Therapeutics Market, growth prospects 2022-2029
• FIG 6. Global Psoriasis Therapeutics Market, porters 5 force model
• FIG 7. Global Psoriasis Therapeutics Market, pest analysis
• FIG 8. Global Psoriasis Therapeutics Market, value chain analysis
• FIG 9. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Psoriasis Therapeutics Market, regional snapshot 2019 & 2029
• FIG 15. North America Psoriasis Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Psoriasis Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Psoriasis Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Psoriasis Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 19. Global Psoriasis Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable